Published in Healthcare Mergers, Acquisitions and Ventures Week, April 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at EPIX Pharmaceuticals.
Report 1: EPIX Pharmaceuticals, Inc. (EPIX) announced that the United States Patent and Trademark Office will issue to EPIX patent number 7,153,858, entitled "New Arylpiperazinyl Compounds."
The granted claims of the patent include the class of selective 5-HT1A binding compounds discovered by EPIX, pharmaceutical compositions containing them, and specific compounds, including PRX-00023.
"This patent is the second U.S. patent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week